Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma

J Transl Med. 2024 Jul 8;22(1):638. doi: 10.1186/s12967-024-05452-9.

Vivian Zhou^#¹, Manya Yu^#^{1

2}, Jiaqi Fu², Siegfried Janz³, Xing Cui⁴

¹ Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
² The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, PRC, China.
³ Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. [email protected].
⁴ Department of Oncology and Hematology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, PRC, China. [email protected].

^# Contributed equally.

No abstract available

Publication types